AIM ImmunoTech
28 hedge funds and large institutions have $1.93M invested in AIM ImmunoTech in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 8 closing their positions.
4% more capital invested
Capital invested by funds: $1.86M → $1.93M (+$66.8K)
15% less funds holding
Funds holding: 33 → 28 (-5)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$8.87K |
| 2 |
Renaissance Technologies
New York
|
+$7.79K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$5.84K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$3.73K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$663 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$28.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$15K |
| 3 |
Bank of New York Mellon
New York
|
-$11.1K |
| 4 |
Jane Street
New York
|
-$9.35K |
| 5 |
VF
Virtu Financial
New York
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $51 | – | – | – |
|
|
HNB
27
Huntington National Bank
Columbus,
Ohio
| $27 | – | – | – |
|
28
UBS Group
Zurich,
Switzerland
| $10 | -$5.35K | -129 | Closed |
|
29
Qube Research & Technologies (QRT)
London,
United Kingdom
| $1 | – | – | – |
|
|
30
Citadel Advisors
Miami,
Florida
| – | -$15K | -341 | Closed |
|
|
31
Bank of New York Mellon
New York
| – | -$11.1K | -253 | Closed |
|
|
32
Jane Street
New York
| – | -$9.35K | -213 | Closed |
|
|
VF
33
Virtu Financial
New York
| – | -$7K | -156 | Closed |
|
|
SFG
34
SNS Financial Group
Minneapolis,
Minnesota
| – | -$4.4K | -100 | Closed |
|
|
TWC
35
TD Waterhouse Canada
Toronto,
Ontario, Canada
| – | -$107 | -2 | Closed |
|
36
Bank of America
Charlotte,
North Carolina
| – | -$41 | -1 | Closed |
|
37
BNP Paribas Financial Markets
Paris,
France
| – | -$1 | – | – |
|
AIM Hedge Fund Activity: Q1 2024 in Review
28 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q1 2024, worth a combined $1.93M — up 3.6% from $1.86M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AIM and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $8.87K. The largest seller was Morgan Stanley, cutting an estimated $28.8K.
- 28 institutional investors held AIM ImmunoTech (AIM) as of Q1 2024, down from 33 in Q4 2023.
- Funds reported $1.93M of AIM ImmunoTech stock for Q1 2024, up 3.6% quarter-over-quarter.
- 3 funds opened new AIM ImmunoTech positions in Q1 2024 and 8 closed out, a net change of -5 holders.
- The largest AIM ImmunoTech buyer in Q1 2024 was Two Sigma Securities, an estimated $8.87K added.
- The largest AIM ImmunoTech seller in Q1 2024 was Morgan Stanley, an estimated $28.8K sold.
Based on aggregated 13F filings for Q1 2024.